(NASDAQ: LSTA) Lisata Therapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 16.02%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 34.54%.
Lisata Therapeutics's earnings in 2026 is -$16,351,000.On average, 3 Wall Street analysts forecast LSTA's earnings for 2026 to be -$8,916,978, with the lowest LSTA earnings forecast at -$8,567,293, and the highest LSTA earnings forecast at -$9,179,242. On average, 3 Wall Street analysts forecast LSTA's earnings for 2027 to be -$6,130,422, with the lowest LSTA earnings forecast at -$5,890,014, and the highest LSTA earnings forecast at -$6,310,729.
In 2028, LSTA is forecast to generate -$9,102,748 in earnings, with the lowest earnings forecast at -$8,745,778 and the highest earnings forecast at -$9,370,476.